In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Soeren Lund Kristensen
Soeren Lund Kristensen
Soeren Lund Kristensen Soeren Lund Kristensen

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)

Specialities : Chronic Heart Failure , Acute Heart Failure, General Cardiology

MD, PhD interested in Heart Failure, Diabetes, Randomized clinical trials and epidemiology

9 presentations from this speaker

Microvascular complications in diabetes patients with heart failure and reduced ejection fraction

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : SL Kristensen (Copenhagen,DK)

Prognostic value of calculated plasma volume status in patients with heart failure and reduced ejection fraction insights from the PARADIGM-HF trial

Event : Heart Failure 2017

  • Session : Rapid Fire 5 - Diagnosis - Pathophysiology - Prognosis
  • Speaker : SL Kristensen (Copenhagen,DK)

Risk related to diabetes and pre-diabetes in heart failure with reduced ejection fraction: Insights from PARADIGM-HF.

Event : ESC Congress 2015

  • Session : Ominous signs in heart failure
  • Speaker : SL Kristensen (Copenhagen,DK)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are